<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
DRMA
Dermata Therapeutics
$
()


  • Fly Intel: Pre-market Movers

    1/5/2024 - 09:02am
  • Dermata Therapeutics up 93% at $1.18 after DMT410 Japan patent announcement

    1/4/2024 - 17:18pm
  • Dermata Therapeutics issues new patent in Japan for DMT410 program

    1/4/2024 - 17:17pm
  • Dermata Therapeutics files to sell 7.19M shares of common stock for holders

    12/7/2023 - 16:07pm
  • Dermata Therapeutics to begin enrollment in DMT310 Phase 3 program in December

    11/16/2023 - 08:23am
  • Dermata Therapeutics files to sell 857K shares of common stock for holders

    7/7/2023 - 16:25pm
  • Dermata announces FDA feedback on DMT310 Phase 3 development program

    6/27/2023 - 09:16am
  • Dermata Therapeutics announces publication on DMT310 Phase 2b results

    6/8/2023 - 09:19am
  • Dermata says results of DMT310 Phase 2b study published in peer-reviewed journal

    6/8/2023 - 09:07am
  • Dermata to sell 800,877 shares at $2.285 in registered direct offering

    5/24/2023 - 08:22am
dynamic_feed Breaking News